USDA scientists reported in the Journal of Virology that they have adapted an experimental African swine fever virus vaccine to grow in a cell line, which would make large-scale production of a vaccine easier. The vaccine candidate was safe and effective when tested with a commercial breed of pigs.
Sign up for FBR SmartBrief
Biomedical Research News
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.